Ipsen

About Ipsen

Ipsen is a global biopharmaceutical group dedicated to the development of innovative medicines in the fields of oncology, neuroscience, and rare diseases. Founded in 1929, the company has established a strong presence in over 100 countries, with a commitment to improving patient outcomes through science and innovation.

With a focus on research and development, Ipsen invests significantly in cutting-edge technologies and collaborations with leading academic institutions. The company’s pipeline includes a range of therapies that address unmet medical needs, particularly in oncology where it aims to provide effective treatments for various types of cancer.

In addition to its robust product portfolio, Ipsen is committed to sustainability and corporate social responsibility. The company actively engages in initiatives that promote health education and access to medicines in underserved communities.

Ipsen’s vision is to be a trusted partner in healthcare, delivering high-quality products and services that enhance the quality of life for patients worldwide. The company values integrity, teamwork, and excellence, which are reflected in its corporate culture.

• Core Areas: Oncology, Neuroscience, Rare Diseases
• Founded: 1929
• Global Presence: Over 100 countries
• Commitment: Innovation, Sustainability, Patient Care

Through its dedication to scientific advancement and patient-centric approaches, Ipsen continues to make significant contributions to the healthcare landscape, striving to meet the evolving needs of patients and healthcare professionals alike.